Grail's Slump Enters Week: Navigating Biotech's Setback
Grail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
Compare ownership costs across dividend ETFs to identify which option offers the best balance of cost, yield, and risk.
22,825 articlesGrail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
Salesforce unveiled a record $25 billion accelerated share repurchase funded by debt as it posted quarterly results. ...
Adobe faces a pivotal shift as its own AI tool accelerates cannibalization of the stock library, forcing a rethinking...
Jeff Immelt debuts a Substack column to speak openly about GE’s legacy and his life after the helm. The move mirrors ...
A 60-year-old who converted $400,000 to a Roth IRA in 2025 plans a $50,000 withdrawal in 2026, only to confront two s...
June offers a chance to get ahead of summer volatility. This article outlines four practical retirement moves to make...
Pershing Square has closed its stake in Universal Music Group after two failed takeover bids, triggering a 7% intrada...
GLDM offers identical gold exposure to GLD but at a fraction of the cost, potentially altering long-term retirement h...
NVIDIA CEO Jensen Huang positioned the latest AI stock pullback as a buying opportunity, a stance that reminds invest...
Jay-Z adds Paris Angeles stadium shows to his 30-year anniversary run signals more than a concert spree. This guide b...
As RH prepares for the (rh) 2026 earnings call, investors want clarity on growth, margins, and strategy. This article...
Perplexity's CEO argues that embracing the risk of idea theft keeps a fast-moving AI startup on its toes. The comment...